Role of Visit Modality in the HIV-Related No-Shows During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study

The emergence of the COVID-19 pandemic necessitated rapid expansion of telehealth as part of healthcare delivery. This study compared HIV-related no-shows by visit type (in-person; video; telephone) during the COVID-19 pandemic (April 2020–September 2021) from the Data for Care Alabama project. Usin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS and behavior 2023-08, Vol.27 (8), p.2478-2487
Hauptverfasser: Sohail, Maira, Long, Dustin, Kay, Emma, Levitan, Emily B., Batey, D. Scott, Reed-Pickens, Harriette, Rana, Aadia, Carodine, Alyssa, Nevin, Christa, Eady, Seqouya, Parmar, Jitesh, Turner, Kelly, Orakwue, Ifeanyi, Miller, Theresa, Wynne, Tracy, Mugavero, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The emergence of the COVID-19 pandemic necessitated rapid expansion of telehealth as part of healthcare delivery. This study compared HIV-related no-shows by visit type (in-person; video; telephone) during the COVID-19 pandemic (April 2020–September 2021) from the Data for Care Alabama project. Using all primary care provider visits, each visit’s outcome was categorized as no-show or arrived. A logistic regression model using generalized estimating equations accounting for repeat measures in individuals and within sites calculated odds ratios (OR) and their accompanying 95% confidence interval (CI) for no-shows by visit modality. The multivariable models adjusted for sociodemographic factors. In-person versus telephone visits [OR (95% CI) 1.64 (1.48–1.82)] and in-person versus video visits [OR (95% CI) 1.53 (1.25–1.85)] had higher odds of being a no-show. In-person versus telephone and video no-shows were significantly higher. This may suggest success of telehealth visits as a method for HIV care delivery even beyond COVID-19.
ISSN:1090-7165
1573-3254
DOI:10.1007/s10461-022-03973-2